Trial intelligence / Profile preview

Lowest effective norepinephrine infusion dose to prevent postspinal hypotension during elective cesarean section in singleton versus twin pregnancy

ChiCTR2000038261Phase 4Recruiting

Sponsor
West China Second University Hospital
Start
Nov 2020
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised, open-label trial of norepinephrine in hypotension (10 arms), sponsored by West China Second University Hospital. Primary endpoints: Blood pressure, ED50 of norepinephrine infusion and 2 more. Started Nov 2020; status: recruiting.

02

Drugs

norepinephrine
03

Conditions

hypotension

Beyond the preview

Go deeper on ChiCTR2000038261.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR2000038261.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call